Date: Tuesday 24 June
Time: 12.25pm - 1.40pm

Overview

Psychosis prediction and prevention is a clinical research priority. But recent research has shown that <10% of psychotic disorders are identified using current "high risk" approaches - the Clinical High Risk and Familial High Risk approaches. This session will describe the state of the art on psychosis prediction and prevention research internationally. It will showcase new findings on the early identification of psychosis risk in mental health services (with a focus on child and adolescent mental health services). It will explain how different approaches within mental health services can capture risk for future psychosis. And it will present cutting edge research on how early-life treatments for common mental health problems (depression, anxiety, ADHD) impact on subsequent psychosis risk.

In this session you will:

• Understand current approaches to identifying psychosis risk
• Understand strengths and limitations of symptom-based assessments (such as Clinical High Risk assessments) in identifying risk for psychosis
• Understand how risk for psychosis is routinely captured in child and adolescent mental health services
• Understand how treatment of common mental health conditions in childhood impacts on subsequent psychosis risk

Speakers

Chair: Professor Ian Kelleher, University of Edinburgh, Edinburgh

Understanding current approaches to identifying psychosis risk

Professor Ian Kelleher, University of Edinburgh, Edinburgh

Identifying psychosis risk in Child and Adolescent Mental Health Services (CAMHS) using healthcare register data

Dr Kirstie O'Hare, University of Edinburgh, Edinburgh

Do attenuated psychotic symptoms predict later psychotic disorders in adolescent psychiatry patients?

Dr Valentina Kieseppä, University of Oulu, Oulu, Finland

How does treatment of common mental health conditions in childhood and adolescence impact on psychosis risk?

Dr Colm Healy, University College Dublin, Dublin